Phathom PharmaceuticalsPHAT

那斯達克 · USD
10.37
+0.15
(+1.47%)
收盤 03/14 03:59 (UTC+8)
03/14 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • 0.01
  • 0.02
  • 0.07
  • 0.16
  • 0.30
  • 0.29
  • 0.40
  • 0.50
  • 0.58
icon
  • -
  • -
  • 180.35
  • 283.05
  • 123.27
  • 81.41
  • -3.86
  • 38.52
  • 25.31
  • 16.32
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
營業收入淨額
57,584
49,503
39,504
28,519
29,664
16,352
7,324
1,912
682
-
營業成本
7,6486,1895,0383,7243,8152,3561,376426167-
營業毛利
49,936
43,314
34,466
24,795
25,849
13,996
5,948
1,486
515
-
營業費用
55,86458,58694,389103,658---71,44070,39035,659
研發費用
7,4937,0279,0769,1848,5838,6937,3769,43013,39412,263
推銷及管理費用
48,37151,55985,31394,47476,68376,09975,87262,01056,99623,396
非經常性項目費用
----------
其他營業費用
----------
營業利益
-5,928
-15,272
-59,923
-78,863
-59,417
-70,796
-77,300
-69,954
-69,875
-35,659
其他收入及費用
1,1991,4071,6302,6183,5593,7033,6184,2703,3342,523
利息費用
16,41916,10817,51718,07118,59318,48417,76417,16813,02910,107
稅前純益
-21,148
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
所得稅
----------
稅後純益
-21,148
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
基本每股稅後盈餘(元)
-0.29-0.41-1.05-1.31-1.05-1.32-1.56-1.42--0.76
稀釋每股稅後盈餘(元)
-0.27-0.41-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75
基本平均股數(千股)
73817.0073396.0072466.0071969.0071044.0064627.0058558.0058371.00-56782.00
稀釋平均股數(千股)
73817.0073396.0072466.0071969.0071044.0064627.0058558.0058371.00-56782.00
還原基本每股稅後盈餘(元)
-0.29-0.41-1.05-1.31-1.05-1.32-1.56-1.42--0.76
還原稀釋每股稅後盈餘(元)
-0.27-0.41-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75
還原基本平均股數(千股)
73,81773,39672,46671,96971,04464,62758,55858,371-56,782
還原稀釋平均股數(千股)
73,81773,39672,46671,96971,04464,62758,55858,371-56,782
EBITDA(千元)
-3,792-12,934-57,387-75,372-55,036-66,313-72,985-64,996-65,790-32,473

大家都在看

HOT